Hyaluronate and risperidone for hemorrhagic cystitis.
Focosi
D
D
Kast
R E
RE
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D000293:Adolescent; D000328:Adult; D003556:Cystitis / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D018492:Dopamine Antagonists / Q000008:administration & dosage*; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007577:JC Virus; D008297:Male; D027601:Polyomavirus Infections / Q000188:drug therapy* / Q000209:etiology; D018967:Risperidone / Q000008:administration & dosage*; D019172:Transplantation Conditioning / Q000009:adverse effects; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D018492:Dopamine Antagonists; D006820:Hyaluronic Acid; D018967:Risperidone